Comparisons between Thyroid Hormone Withdrawal and Recombinant Human Thyroid-stimulating Hormone Administration for Radioiodine Ablation in Patients with Intermediate-risk to High-risk Differentiated Thyroid Cancer

被引：0
|
作者：
Iizuka, Y. [1 ]
Katagiri, T. [1 ]
Ogura, K. [1 ]
Inoue, M. [1 ]
Nakamura, K. [1 ]
Mizowaki, T. [1 ]
机构：
[1] Kyoto Univ, Kyoto, Japan
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-359
引用
收藏
页码：S141 / S141
页数：1
相关论文
共 50 条
  • [31] Correlation analyses of thyroid-stimulating hormone and thyroid autoantibodies with differentiated thyroid cancer
    Zhang, Xuefeng
    Zhang, Xueqi
    Change, Zhexing
    Wu, Cuicui
    Guo, Hang
    JOURNAL OF BUON, 2018, 23 (05): : 1467 - 1471
  • [32] Comparison of the influence on the liver function between thyroid hormone withdrawal group and recombinant human thyroid stimulating hormone group before high-dose radioiodine therapy in the patients with well-differentiated thyroid cancer
    Han, Yeon-hee
    Jeong, Young Jin
    Kim, Dong Wook
    Jeong, Hwan-Jeong
    Lim, Seok Tae
    Sohn, Myung-Hee
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [33] Higher preablative serum thyroid-stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma
    Lawal, Ismaheel O.
    Nyakale, Nozipho E.
    Harry, Lerwine M.
    Lengana, Thabo
    Mokgoro, Neo P.
    Vorster, Mariza
    Sathekge, Mike M.
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (03) : 222 - 227
  • [34] Comparison of the biological activity of recombinant human thyroid-stimulating hormone with bovine thyroid-stimulating hormone and evaluation of recombinant human thyroid-stimulating hormone in healthy dogs of different breeds
    Boretti, FS
    Sieber-Ruckstuhl, NS
    Willi, B
    Lutz, H
    Hofmann-Lehmann, R
    Reusch, CE
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2006, 67 (07) : 1169 - 1172
  • [35] Using recombinant human thyroid-stimulating hormone for the diagnosis of recurrent thyroid cancer
    Blamey, S
    Barraclough, B
    Delbridge, L
    Mernagh, P
    Standfield, L
    Weston, A
    ANZ JOURNAL OF SURGERY, 2005, 75 (1-2) : 10 - 20
  • [36] Recombinant human thyroid-stimulating hormone: Use in papillary and follicular thyroid cancer
    Schlumberger, Martin
    Borget, Isabelle
    De Pouvourville, Gerard
    Pacini, Furio
    HORMONE RESEARCH, 2007, 67 : 132 - 142
  • [37] Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
    Piccardo, Arnoldo
    Puntoni, Matteo
    Ferrarazzo, Giulia
    Foppiani, Luca
    Bottoni, Gianluca
    Altrinetti, Vania
    Treglia, Giorgio
    Naseri, Mehrdad
    Dib, Bassam
    Cabria, Manlio
    Trimboli, Pierpaolo
    Massollo, Michela
    Giovanella, Luca
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (07) : 1218 - 1223
  • [38] Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
    Arnoldo Piccardo
    Matteo Puntoni
    Giulia Ferrarazzo
    Luca Foppiani
    Gianluca Bottoni
    Vania Altrinetti
    Giorgio Treglia
    Mehrdad Naseri
    Bassam Dib
    Manlio Cabria
    Pierpaolo Trimboli
    Michela Massollo
    Luca Giovanella
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1218 - 1223
  • [39] Recombinant Human Thyroid Stimulating Hormone versus Thyroid Hormone Withdrawal for Radioactive Iodine Treatment of Differentiated Thyroid Cancer with Nodal Metastatic Disease
    Wolfson, Robert M.
    Rachinsky, Irina
    Morrison, Deric
    Driedger, Al
    Spaic, Tamara
    van Uum, Stan H. M.
    JOURNAL OF ONCOLOGY, 2016, 2016
  • [40] Cost-effectiveness of using recombinant human thyroid-stimulating hormone before radioiodine ablation for thyroid cancer treatment in Spanish hospitals
    Vallejo, J. A.
    Muros, M. A.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2017, 36 (06): : 362 - 370
12345